Anas Alharbi

Papers

Total Citations

H-Index

About

Dr. Anas Alharbi is a leading cardiovascular surgeon whose research focuses on advancing minimally invasive and robotic approaches to valvular heart disease. His most impactful work directly compares the outcomes of robotic aortic valve replacement (RAVR) against transcatheter aortic valve replacement (TAVR), a pivotal area of debate in modern cardiology. In his 2024 propensity-matched analysis, Dr. Alharbi demonstrated that RAVR offers comparable safety and efficacy to TAVR, with potential advantages in long-term valve durability and lower rates of paravalvular leak. This study, already garnering 11 citations, provides critical evidence for surgical decision-making in high-risk patients. Beyond this landmark paper, Dr. Alharbi’s contributions extend to refining robotic surgical techniques and optimizing perioperative care, helping to establish robotics as a viable alternative to both traditional open surgery and catheter-based interventions. His work is widely cited by cardiothoracic surgeons and interventional cardiologists, shaping clinical guidelines and training protocols. Dr. Alharbi’s research is instrumental in defining the future of aortic valve therapy, bridging the gap between surgical and transcatheter approaches.